José Antonio
Páramo Fernández
Catedrático de Universidad
Clínica Universitaria de Navarra
Pamplona, EspañaPublications in collaboration with researchers from Clínica Universitaria de Navarra (114)
2024
-
Immunothrombosis: A key mechanism in the COVID-19 pandemic
Medicina Clinica
-
Is tranexamic acid appropriate for all patients undergoing high-risk surgery?
Current Opinion in Critical Care
-
Novel biomarkers and psoriasis associated cardiovascular risk
Archives of Dermatological Research, Vol. 316, Núm. 5
-
Role of factor XIII in ischemic stroke: a key molecule promoting thrombus stabilization and resistance to lysis
Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 4, pp. 1080-1093
2021
-
Microvascular thrombosis and clinical implications
Medicina Clinica, Vol. 156, Núm. 12, pp. 609-614
-
Prediction and treatment of bleeding in patients under anticoagulant treatment
Medicina Clinica, Vol. 156, Núm. 1, pp. 20-25
-
Treatment of haemophilia: From replacement to gene therapy
Medicina Clinica, Vol. 157, Núm. 12, pp. 583-587
2019
-
Improvement of appropriate pharmacological prophylaxis in hospitalised cancer patients with a multiscreen e-alert system: a single-centre experience
Clinical and Translational Oncology, Vol. 21, Núm. 6, pp. 805-809
2018
2017
-
Los pacientes con placas coronarias vulnerables presentan mayores niveles séricos de metaloproteinasa-1
Anales del sistema sanitario de Navarra, Vol. 40, Núm. 1, pp. 35-42
-
Reduced high-density lipoprotein cholesterol: A valuable, independent prognostic marker in peripheral arterial disease
Journal of Vascular Surgery, Vol. 66, Núm. 5, pp. 1527-1533.e1
2016
-
Identification of new markers of recurrence in patients with unprovoked deep vein thrombosis by gene expression profiling: the retro study
European Journal of Haematology, Vol. 97, Núm. 2, pp. 128-136
2015
-
Factors influencing the use of thromboprophylaxis in cancer outpatients in clinical practice: A prospective study
Thrombosis Research, Vol. 136, Núm. 6, pp. 1145-1148
-
Increased levels of metalloproteinase 10 and hemostatic markers in patients with noncomplicated primary varicose veins
Clinical and Applied Thrombosis/Hemostasis, Vol. 21, Núm. 7, pp. 684-687
-
Matrix Metalloproteinase 10 Contributes To Hepatocarcinogenesis in a Novel Crosstalk With the Stromal Derived Factor 1/C-X-C Chemokine Receptor 4 Axis
Hepatology, Vol. 62, Núm. 1, pp. 166-178
-
Matrix metalloproteinase 10 is associated with disease severity and mortality in patients with peripheral arterial disease
Journal of Vascular Surgery, Vol. 61, Núm. 2, pp. 428-435
-
Short-term heparin re-exposure during heart transplantation in patients with ventricular assist devices and acute heparin-induced thrombocytopenia
Revista Espanola de Cardiologia
2014
-
Arteriosclerosis in the 21st century
Angiologia, Vol. 66, Núm. 3, pp. 109-111
-
Haemostatic activation and inflammatory response after three methods of treatment of great saphenous vein incompetence
Phlebology, Vol. 29, Núm. 3, pp. 154-163
-
Venous and arterial thrombosis: Similarities and clinical implications
Medicina Clinica, Vol. 143, Núm. 1, pp. 20-21